Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 10:39 PM
Study NCT ID:
NCT00784667
Status:
UNKNOWN
Last Update Posted:
2010-11-30
First Post:
2008-11-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib
Sponsor:
Austin Health
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
H2008/03282
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr Niall Tebbutt
Old Organization:
Austin Health